Similar articles for PMID: 23738667

Year	Number of Results
1999	1
2003	1
2006	1
2008	2
2009	5
2010	1
2011	5
2012	3
2013	11
2014	6
2015	13
2016	15
2017	10
2018	13
2019	7
2020	15
2021	6
2022	9
2023	1
2024	0

1

Therapeutic nanomedicine for brain cancer.

Tzeng SY, Green JJ. Tzeng SY, et al. Ther Deliv. 2013 Jun;4(6):687-704. doi: 10.4155/tde.13.38. Ther Deliv. 2013. PMID: 23738667 Free PMC article. Review.

2

Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.

Mangraviti A, Tzeng SY, Kozielski KL, Wang Y, Jin Y, Gullotti D, Pedone M, Buaron N, Liu A, Wilson DR, Hansen SK, Rodriguez FJ, Gao GD, DiMeco F, Brem H, Olivi A, Tyler B, Green JJ. Mangraviti A, et al. ACS Nano. 2015 Feb 24;9(2):1236-49. doi: 10.1021/nn504905q. Epub 2015 Feb 10. ACS Nano. 2015. PMID: 25643235 Free PMC article.

3

Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.

Ferraris C, Cavalli R, Panciani PP, Battaglia L. Ferraris C, et al. Int J Nanomedicine. 2020 Apr 30;15:2999-3022. doi: 10.2147/IJN.S231479. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32431498 Free PMC article. Review.

4

Novel Nanotechnologies for Brain Cancer Therapeutics and Imaging.

Ferroni L, Gardin C, Della Puppa A, Sivolella S, Brunello G, Scienza R, Bressan E, D'Avella D, Zavan B. Ferroni L, et al. J Biomed Nanotechnol. 2015 Nov;11(11):1899-912. doi: 10.1166/jbn.2015.2074. J Biomed Nanotechnol. 2015. PMID: 26554151 Review.

5

T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.

Kuang Y, An S, Guo Y, Huang S, Shao K, Liu Y, Li J, Ma H, Jiang C. Kuang Y, et al. Int J Pharm. 2013 Sep 15;454(1):11-20. doi: 10.1016/j.ijpharm.2013.07.019. Epub 2013 Jul 15. Int J Pharm. 2013. PMID: 23867728

6

Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.

Chaichana KL, Pinheiro L, Brem H. Chaichana KL, et al. Ther Deliv. 2015 Mar;6(3):353-69. doi: 10.4155/tde.14.114. Ther Deliv. 2015. PMID: 25853310 Free PMC article. Review.

7

Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity.

Brighi C, Reid L, Genovesi LA, Kojic M, Millar A, Bruce Z, White AL, Day BW, Rose S, Whittaker AK, Puttick S. Brighi C, et al. Theranostics. 2020 May 15;10(14):6361-6371. doi: 10.7150/thno.46468. eCollection 2020. Theranostics. 2020. PMID: 32483457 Free PMC article.

8

Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.

Nafee N, Gouda N. Nafee N, et al. Curr Gene Ther. 2017;17(2):154-169. doi: 10.2174/1566523217666170510155803. Curr Gene Ther. 2017. PMID: 28494740 Review.

9

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D. Juratli TA, et al. Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Pharmacol Ther. 2013. PMID: 23694764 Review.

10

Harnessing nanomedicine for therapeutic intervention in glioblastoma.

Gutkin A, Cohen ZR, Peer D. Gutkin A, et al. Expert Opin Drug Deliv. 2016 Nov;13(11):1573-1582. doi: 10.1080/17425247.2016.1200557. Epub 2016 Jun 27. Expert Opin Drug Deliv. 2016. PMID: 27292970 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year